Skip to main content

Table 2 Adverse events associated with intralymphatic injections

From: Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

  Active ILIT (61 injections) Placebo ILIT (45 injections)
  Early Reactions Late Reactions Early Reactions Late Reactions
Local Lymph Node Swelling Mild: 6 Mild: 14 Mild: 1 Mild: 1
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Local Itch Mild: 6 Mild: 11 Mild: 2 Mild: 1
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Local Redness Mild: 11 Mild: 21 Mild: 0 Mild: 0
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Nasal Symptoms Mild: 1 Mild: 1 Mild: 4 Mild: 4
Moderate: 0 Moderate: 0 Moderate: 0 Moderate:0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Pulmonary Symptoms Mild: 0 Mild: 0 Mild: 0 Mild: 0
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Urticaria and angiooedema Mild: 1 Mild: 4 Mild: 0 Mild: 1
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0
Abdominal Symptoms Mild: 0 Mild: 1 Mild: 0 Mild: 1
Moderate: 0 Moderate: 0 Moderate: 0 Moderate: 0
Severe: 0 Severe: 0 Severe: 0 Severe: 0